CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flow from operating activities:
Net loss	$ (2,507,234)	$ (591,459)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Derivative expense	18,209	109,673
Impairment Loss - Note 1	1,575,000
Amortization of intangible assets	274,456	344,272
Deferred income taxes	(171,008)	(122,880)
Extinguishment loss		130,055
Minority interest	(6,294)	(6,294)
Share-based compensation	194,750	262,550
Depreciation	72,554	29,489
(Increase) decrease in:
Accounts receivable	158,657	469,515
Other current assets	7,172	16,582
Other assets		6,997
Increase (decrease) in:
Accounts payable and accrued liabilities	(603,452)	(53,854)
Deferred revenues	(67,879)
Customer advances	125,267	154,225
Total adjustments	1,577,432	1,340,330
Net cash provided by (used for) operating activities	(929,802)	748,871
Cash Used in investing activities:
Purchase of intangibles		(1,300,000)
Acquired cash - CLR	59,518
Purchase of equipment	(263,582)	(30,427)
Net cash used for investing activities	(204,064)	(1,330,427)
Cash flows from financing activities:
Revolving credit facility (payments) borrowings, net	(103,612)	(45,714)
Payments on captial equipment lease	(25,658)	(19,169)
Payments Notes payable	(589,275)
Proceeds from issuance of securities, net	1,937,461	1,350,000
Loans paid director	(13,746)	(80,441)
Net cash provided by (used in) financing activities	1,205,170	1,204,676
Net increase (decrease) in cash and cash equivalents	71,304	623,120
Cash and cash equivalents - beginning of period	324,149	212,616
Cash and cash equivalents - end of period	395,454	835,736
Supplemental cash flow information
Interest paid in cash	218,618	172,168
Taxes paid
Supplemental disclosures of Non-Cash Investing & Financing Activities
Proceeds from Factoring agreement paid directly to Private Bank Facility
Exercise of warrants
Common Stock	1,231
Derivative liabilities	(31,999)
Additonal paid in capital	30,768
Conversion of preferred shares into common		(14,370)
Conversion of preferred shares into common		51,322
Additonal paid in capital		(36,951)
Exchange of warrants for preferred series A
Derivative liabilities		87,785
Additional paid in Capital		453,840
Deferred financing fees		150,000
Purchase of Cummings Creek/CLR
Common Stock	25,000
Additional paid in Capital	$ 522,000